Literature DB >> 19051220

A graphical approach to sequentially rejective multiple test procedures.

Frank Bretz1, Willi Maurer, Werner Brannath, Martin Posch.   

Abstract

For clinical trials with multiple treatment arms or endpoints a variety of sequentially rejective, weighted Bonferroni-type tests have been proposed, such as gatekeeping procedures, fixed sequence tests, and fallback procedures. They allow to map the difference in importance as well as the relationship between the various research questions onto an adequate multiple test procedure. Since these procedures rely on the closed test principle, they usually require the explicit specification of a large number of intersection hypotheses tests. The underlying test strategy may therefore be difficult to communicate. We propose a simple iterative graphical approach to construct and perform such Bonferroni-type tests. The resulting multiple test procedures are represented by directed, weighted graphs, where each node corresponds to an elementary hypothesis, together with a simple algorithm to generate such graphs while sequentially testing the individual hypotheses. The approach is illustrated with the visualization of several common gatekeeping strategies. A case study is used to illustrate how the methods from this article can be used to tailor a multiple test procedure to given study objectives.

Mesh:

Year:  2009        PMID: 19051220     DOI: 10.1002/sim.3495

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  52 in total

1.  A shortcut for multiple testing on the directed acyclic graph of gene ontology.

Authors:  Garrett Saunders; John R Stevens; S Clay Isom
Journal:  BMC Bioinformatics       Date:  2014-11-01       Impact factor: 3.169

2.  Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.

Authors:  Frank Bretz; Martin Posch; Ekkehard Glimm; Florian Klinglmueller; Willi Maurer; Kornelius Rohmeyer
Journal:  Biom J       Date:  2011-08-12       Impact factor: 2.207

3.  Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

Authors:  Alireza Atri; Lutz Frölich; Clive Ballard; Pierre N Tariot; José Luis Molinuevo; Neli Boneva; Kristian Windfeld; Lars L Raket; Jeffrey L Cummings
Journal:  JAMA       Date:  2018-01-09       Impact factor: 56.272

4.  A modest proposal for dropping poor arms in clinical trials.

Authors:  Michael A Proschan; Lori E Dodd
Journal:  Stat Med       Date:  2014-04-22       Impact factor: 2.373

5.  Anomalous morphology in left hemisphere motor and premotor cortex of children who stutter.

Authors:  Emily O Garnett; Ho Ming Chow; Alfonso Nieto-Castañón; Jason A Tourville; Frank H Guenther; Soo-Eun Chang
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

6.  Incorporating biomarkers to improve statistical power of immunotherapeutic neoadjuvant clinical trials in patients with triple-negative breast cancer.

Authors:  Feng Gao; Guoqiao Wang; Jingqin Luo; Jingxia Liu; Ling Chen; Chengjie Xiong
Journal:  Stat Biopharm Res       Date:  2019-04-18       Impact factor: 1.452

Review 7.  Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation.

Authors:  Mei-Yin C Polley; Edward L Korn; Boris Freidlin
Journal:  JCO Precis Oncol       Date:  2019-10-24

8.  Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

Authors:  Jiacheng Yuan; Herbert Pang; Tiejun Tong; Dong Xi; Wenzhao Guo; Peter Mesenbrink
Journal:  J Biopharm Stat       Date:  2015-09-21       Impact factor: 1.051

9.  On Consistency of Self- and Proxy-reported Regular Smoking Initiation Age.

Authors:  Julia N Soulakova; Brianna C Bright; Lisa J Crockett
Journal:  J Subst Abus Alcohol       Date:  2013-12-16

10.  Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.

Authors:  Richard B Lipton; David W Dodick; Jessica Ailani; Kaifeng Lu; Michelle Finnegan; Armin Szegedi; Joel M Trugman
Journal:  JAMA       Date:  2019-11-19       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.